Tumor immune escape mechanisms: impact of the neuroendocrine system (Q36376833)

13 August 2017

1 reference

title

Tumor immune escape mechanisms: impact of the neuroendocrine system (English)

1 reference

evasion of host immune response

13 August 2017

main subject

1 reference

Kerstin Lang

1 reference

13 August 2017

Frank Entschladen

series ordinal

1 reference

13 August 2017

Corinna Weidt

series ordinal

1 reference

13 August 2017

Kurt S Zaenker

series ordinal

1 reference

13 August 2017

publication date

25 January 2006

1 reference

Cancer Immunology, Immunotherapy

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

749-760

1 reference

Neurotrophins and neurotrophin receptors in human lung cancer

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

Going both ways: immune regulation via CD1d-dependent NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

Peptidergic innervation of human esophageal and cardiac carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0126-X

10.1007/S00262-006-0126-X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference